By Beth Winegarner ( November 13, 2014, 7:51 PM EST) -- Abbott Laboratories urged a California federal judge on Thursday to rule it didn't violate antitrust or deceptive trade laws when it raised prices on an HIV drug it had licensed to GlaxoSmithKline, saying a retrial ordered by the Ninth Circuit should be limited to GSK's contract claims....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.